
Sign up to save your podcasts
Or


Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643
By Michael Putman4.9
114114 ratings
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643

504 Listeners

295 Listeners

126 Listeners

3,375 Listeners

1,145 Listeners

119 Listeners

194 Listeners

520 Listeners

66 Listeners

5 Listeners

377 Listeners

181 Listeners

190 Listeners

20 Listeners

5 Listeners